XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Jan. 28, 2023
Jan. 29, 2022
Jan. 28, 2023
Jan. 29, 2022
Sales:        
Product sales and other $ 402,755 $ 377,713 $ 1,231,465 $ 1,182,812
Total sales 447,064 402,798 1,328,020 1,270,569
bned_Cost of Product and Other Cost of Sales 319,644 297,693 963,071 924,924
Rental cost of sales 23,210 18,144 52,416 53,096
Cost of Goods and Services Sold 342,854 315,837 1,015,487 978,020
Gross profit 104,210 86,961 312,533 292,549
Selling and administrative expenses 99,473 101,460 305,045 295,597
Depreciation and amortization expense 10,618 12,179 33,910 36,755
Restructuring and other charges 5,975 46 6,610 3,067
Operating (loss) income (17,864) (33,135) (39,040) (49,281)
Interest expense, net 6,918 3,051 15,672 7,809
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total (24,782) (36,186) (54,712) (57,090)
Income tax expense (benefit) 267 615 900 811
Net (loss) income $ (25,049) $ (36,801) $ (55,612) $ (57,901)
(Loss) Earnings per share of common stock        
Basic $ (0.48) $ (0.71) $ (1.06) $ (1.12)
Diluted $ (0.48) $ (0.71) $ (1.06) $ (1.12)
Weighted average common shares outstanding        
Diluted 52,602 52,003 52,404 51,714
Basic 52,602 52,003 52,404 51,714
Other Nonrecurring Expense $ 6,008 $ 6,411 $ 6,008 $ 6,411